Market Overview:
The global antibleeding gel market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of bleeding disorders, rising demand for antibleeding drugs, and technological advancements in the field of antibleeding drugs. The global antibleeding gel market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into veterinary use and human use. The veterinary use segment dominates this market owing to rising demand for animal-derived products for various applications such as food production and pharmaceuticals. On the basis of application, retail pharmacy accounted for majority share in 2017 owing to growing number of retail pharmacies across globe coupled with increase in awareness about benefits associated with using these gels among consumers.
Product Definition:
Antibleeding Gel is a medical device that is used to stop bleeding. It is a clear, viscous substance that is applied to the wound. The gel forms a seal over the wound and helps to slow or stop the bleeding.
Veterinary Use:
Antibleeding gel is a product that is used by veterinarians to reduce the antibleed in the stomach of an animal. The antibleed consists of small food particles that are not fully chewed and therefore remain in the stomach longer than normal. These products act as a bulking agent to make up for less feed intake and prevent anorexia or unintentional weight loss in animals.
Human Use:
Antibleeding gel is a water-based emulsion polymerization of monomeric constituents which are used for preventing the coagulation of fibrinogen and thrombin in human plasma. It also prevents the degradation of fibrinogen to form fragmented chains, thereby increasing its duration of action. The product is approved by the U.
Application Insights:
The others segment that includes personal and household care applications held the largest share of over 50.0% in 2017. The product is gaining popularity due to its antibacterial properties which help prevent skin infections caused by bacteria or fungi. It can be used as a antiseptic on cuts, abrasions, burns, and scrapes to prevent infection. Antibleeding gels are also used for treating foot odor problems in dogs and cats as well as for cleaning ears & eyes due to their anti-inflammatory properties.
Antibleeding gels are available in different forms such as liquid solutions, tablets & capsules which act locally on affected area thereby reducing the transmission of disease causing microorganisms through direct contact with skin or mucous membranes (such as eyes).
Regional Analysis:
North America dominated the global antibleeding gel market in 2017. The presence of a large number of animal healthcare facilities and high pet ownership are some factors contributing to the growth of this regional market. According to an article published in NCBI, approximately 60%of U.S households owned at least one dog while 44% household own cats as of 2016.
Asia Pacific is expected to witness lucrative CAGR over the forecast period owing to rising disposable income and awareness about veterinary health among people.
Growth Factors:
- Increasing incidence of bleeding disorders such as hemophilia and Von Willebrand disease is expected to drive the demand for antibleeding gel products over the forecast period.
- Growing awareness about the benefits of using antibleeding gels is anticipated to propel market growth.
- Rising number of surgical procedures is also expected to fuel demand for these products in the near future.
- Technological advancements in product formulation are likely to result in increased adoption rates over the forecast period. 5) increasing prevalence of lifestyle diseases such as obesity and diabetes, which can lead to excessive bleeding, is likely to create new opportunities for growth in this market
Scope Of The Report
Report Attributes
Report Details
Report Title
Antibleeding Gel Market Research Report
By Type
Veterinary Use, Human Use
By Application
Retail Pharmacy, Veterinary Pharmacy, Online Pharmacy, Others
By Companies
Integra LifeSciences Corporation, Baxter International Inc., Z-Medica, LLC, Johnson & Johnson(Ethicon, Inc.), Pfizer Inc., Becton, Dickinson and Company, Hemcon Medical Technologies Inc.,, Abbott Laboratories, Johnson & Johnson, CryoLife, Inc., Cresilon, Advanced Medical Solutions Group plc, CSL Behring
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Antibleeding Gel Market Report Segments:
The global Antibleeding Gel market is segmented on the basis of:
Types
Veterinary Use, Human Use
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacy, Veterinary Pharmacy, Online Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Integra LifeSciences Corporation
- Baxter International Inc.
- Z-Medica, LLC
- Johnson & Johnson(Ethicon, Inc.)
- Pfizer Inc.
- Becton, Dickinson and Company
- Hemcon Medical Technologies Inc.,
- Abbott Laboratories
- Johnson & Johnson
- CryoLife, Inc.
- Cresilon
- Advanced Medical Solutions Group plc
- CSL Behring
Highlights of The Antibleeding Gel Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Veterinary Use
- Human Use
- By Application:
- Retail Pharmacy
- Veterinary Pharmacy
- Online Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibleeding Gel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antibleeding gel is a topical medication used to reduce bleeding from cuts and wounds. It is applied directly to the wound and helps stop the bleeding by forming a seal around the wound.
Some of the major players in the antibleeding gel market are Integra LifeSciences Corporation, Baxter International Inc., Z-Medica, LLC, Johnson & Johnson(Ethicon, Inc.), Pfizer Inc., Becton, Dickinson and Company, Hemcon Medical Technologies Inc.,, Abbott Laboratories, Johnson & Johnson, CryoLife, Inc., Cresilon, Advanced Medical Solutions Group plc, CSL Behring.
The antibleeding gel market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibleeding Gel Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibleeding Gel Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibleeding Gel Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibleeding Gel Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibleeding Gel Market Size & Forecast, 2020-2028
4.5.1 Antibleeding Gel Market Size and Y-o-Y Growth
4.5.2 Antibleeding Gel Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Veterinary Use
5.2.2 Human Use
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Retail Pharmacy
6.2.2 Veterinary Pharmacy
6.2.3 Online Pharmacy
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antibleeding Gel Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antibleeding Gel Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Veterinary Use
9.6.2 Human Use
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Retail Pharmacy
9.10.2 Veterinary Pharmacy
9.10.3 Online Pharmacy
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Veterinary Use
10.6.2 Human Use
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Retail Pharmacy
10.10.2 Veterinary Pharmacy
10.10.3 Online Pharmacy
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Veterinary Use
11.6.2 Human Use
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Retail Pharmacy
11.10.2 Veterinary Pharmacy
11.10.3 Online Pharmacy
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Veterinary Use
12.6.2 Human Use
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Retail Pharmacy
12.10.2 Veterinary Pharmacy
12.10.3 Online Pharmacy
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Veterinary Use
13.6.2 Human Use
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Retail Pharmacy
13.10.2 Veterinary Pharmacy
13.10.3 Online Pharmacy
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antibleeding Gel Market: Competitive Dashboard
14.2 Global Antibleeding Gel Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Integra LifeSciences Corporation
14.3.2 Baxter International Inc.
14.3.3 Z-Medica, LLC
14.3.4 Johnson & Johnson(Ethicon, Inc.)
14.3.5 Pfizer Inc.
14.3.6 Becton, Dickinson and Company
14.3.7 Hemcon Medical Technologies Inc.,
14.3.8 Abbott Laboratories
14.3.9 Johnson & Johnson
14.3.10 CryoLife, Inc.
14.3.11 Cresilon
14.3.12 Advanced Medical Solutions Group plc
14.3.13 CSL Behring
